TCTR20171127003招募中2 期
Clinical Outcomes of Stereotactic Body Radiation Therapy (SBRT) Using Flattening Filter Free (FFF) in Early Non-small Cell Lung Cancers (NSCLC) and Metastatic Lung Cancers.
none0 个研究点目标入组 138 人开始时间: 2017年11月27日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 138
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 0 N/A (No limit) 至 0 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Patients with early NSCLC or lung metastases treated with SBRT using FFF.
- •2. Adequate follow up period of more than 6 months after SBRT
排除标准
- •1. Incomplete documented medical records or inaccessible data
- •2. Incomplete treatment
研究者
相似试验
已完成
不适用
The efficacy of stereotactic body radiation therapy for unresectable hepatocellular carcinoma: a single institution phase II studyKCT0000625Asan Medical Center50
已完成
不适用
Efficacy of stereotactic body radiotherapy in primary renal cell carcinomaKCT0007835Asan Medical Center40
尚未招募
不适用
Stereotactic ablative body radiotherapy for Unresectable Pancreatic cancer with Endoscopic ultrasound inserted fiducial markers and concuRrent chemotherapy (SUPER) trial.Pancreatic cancer tumoursACTRN12617001571369Royal Adelaide Hospital250
招募中
1 期
Phase I study of postoperative stereotactic body radiotherapy for prostate cancerprostate cancerJPRN-jRCT1030220062Yamashita Hideomi36
已完成
2 期
Phase II trial of stereotactic body radiotherapy with a hydrogel spacer for prostate cancerProstate cancerJPRN-UMIN000026213The University of Tokyo Hospital42